EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Contributions of Clinical Obesity and Preclinical Obesity to the All‐Cause Mortality Risk: Findings From the UK Biobank Cohort

Manrong Xu, Menghan Li, Yawen Zhang, Lianxi Li iD, Yun Shen iD, Gang Hu iD

Diabetes/Metabolism Research and Reviews · 2025-10 · 41 (7)

DOI: 10.1002/dmrr.70095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes/Metabolism Research and Reviews, online erschienen am 16.10.2025. Verfasst von Manrong Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinica…. Hauptthemen laut MEDLINE: Obesity. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, Collaboration in Action Program 2024 supported by Our Lady of the Lake Health & Louisiana State University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The definition of clinical obesity was newly announced. The aim of our study was to investigate the association of preclinical obesity and clinical obesity either at baseline or determined during follow‐ups with the risk of all‐cause mortality.

Methods

Data were collected from 232,721 participants in the UK Biobank. Dysfunctions caused by obesity, in combination with an excess of anthropometric parameters, were used to diagnose clinical obesity. Participants were categorised into six clusters according to their baseline and follow‐up dysfunction status. Time‐dependent Cox proportional hazards regression was used to compare hazard ratios (HRs) for mortality across six clusters.

Results

In a total of 19,704 deaths over a mean follow‐up of 13.4 years, participants in Cluster 6 (clinical obesity at baseline; HR = 2.30, 95% CI: 2.16–2.44) and Cluster 3 (non‐obesity with baseline dysfunctions; HR = 2.02, 95% CI: 1.85–2.20) exhibited the highest multivariable‐adjusted mortality risk compared with participants without obesity and dysfunction at baseline and during follow‐up (Cluster 1). This was followed by participants in Cluster 2 (non‐obesity without baseline but with follow‐up dysfunctions; HR = 1.99, 95% CI: 1.88–2.10), Cluster 5 (preclinical obesity with follow‐up dysfunctions; HR = 1.97, 95% CI: 1.87–2.07), and Cluster 4 (preclinical obesity without follow‐up dysfunctions; HR = 1.15, 95% CI: 1.09–1.22). Subgroup analyses showed consistently higher mortality risks in Cluster 6 across various demographics, notably among individuals with higher educational qualifications.

Conclusions

Clinical obesity was significantly associated with elevated all‐cause mortality risk. These findings underscore the importance of early screening and intervention for dysfunctions in patients with obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityHumansFemaleMaleUnited KingdomMiddle AgedBiological Specimen BanksFollow-Up StudiesRisk FactorsAgedBody Mass IndexAdultCause of DeathCohort StudiesPrognosisSurvival RateUK Biobank

Stichwörter der Autor:innen

UK biobankall‐cause mortalityclinical obesitydysfunctions due to obesitypreclinical obesity

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Sixth People's Hospital Affil…
  • Chronic Disease Epidemiology Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.

ORCID-Profile: Lianxi Li, Yun Shen, Gang Hu

Förderung

  • NIGMS NIH HHS
  • Collaboration in Action Program 2024 supported by Our Lady of the Lake Health & Louisiana State University
  • National Natural Science Foundation of China
  • National Institute of General Medical Sciences

Zitieren

APA

Xu, M., Li, M., Zhang, Y., Li, L., Shen, Y., & Hu, G. (2025). Contributions of Clinical Obesity and Preclinical Obesity to the All‐Cause Mortality Risk: Findings From the UK Biobank Cohort. Diabetes/Metabolism Research and Reviews, 41(7). https://doi.org/10.1002/dmrr.70095

Vancouver

Xu M, Li M, Zhang Y, Li L, Shen Y, Hu G. Contributions of Clinical Obesity and Preclinical Obesity to the All‐Cause Mortality Risk: Findings From the UK Biobank Cohort. Diabetes/Metabolism Research and Reviews. 2025;41(7). doi:10.1002/dmrr.70095

BibTeX
@article{Xu2025,
  author = {Xu, Manrong and Li, Menghan and Zhang, Yawen and Li, Lianxi and Shen, Yun and Hu, Gang},
  title = {Contributions of Clinical Obesity and Preclinical Obesity to the All‐Cause Mortality Risk: Findings From the UK Biobank Cohort},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2025},
  volume = {41},
  number = {7},
  doi = {10.1002/dmrr.70095}
}
Kostenlos starten →